Search for: "LaBelle v. LaBelle"
Results 121 - 140
of 12,213
Sorted by Relevance
|
Sort by Date
18 Sep 2017, 6:39 am
This Article demonstrates that—as suggested in the dissenting opinion in United States v. [read post]
7 Sep 2010, 6:14 am
" Hoffmann-La Roche Inc. v. [read post]
7 Aug 2015, 1:51 pm
In our prior posts about Amarin Pharma, Inc. v. [read post]
11 Jan 2022, 12:00 am
” The Court took pains to distinguish Hikma’s labeling and promotion from Teva’s in GSK v. [read post]
23 Aug 2011, 3:37 pm
Record Labels Get Hollow Victory in MP3tunes Infringement Case :: Capitol Records v. [read post]
15 Apr 2016, 6:30 am
The Ninth Circuit, home of the infamous “Food Court,” has now invoked that doctrine and has ordered the stay of a pending “natural” mislabeling class action in Kane v. [read post]
15 Jun 2015, 1:50 pm
See, e.g., Caplinger v. [read post]
15 Sep 2024, 9:11 am
MGA Entertainment The post Record Label Sends Bogus Takedown Notice, Defeats 512(f) Claim Anyway–White v. [read post]
22 Jan 2013, 8:50 am
Nathan v. [read post]
15 Oct 2018, 4:50 am
For example, 27 CFR 4.35(a)(2)(v) defines “vinted”—when used in the name/address statement on the label—to mean that “the named winery, at the stated address, subjected the wine to cellar treatment in accordance with §4.22(c). [read post]
2 Jun 2020, 1:23 pm
Hesse v. [read post]
7 Jan 2016, 12:00 am
Ass'n v. [read post]
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
19 Feb 2010, 4:10 am
In an (unfortunately) not-for-publication opinion, the 9th Circuit affirmed a defense summary judgment in Carson v. [read post]
23 Mar 2021, 6:00 am
Warning letter language often states that the offending product is a: “new animal drug, as defined by section 201(v) of the FD&C Act, 21 U.S.C. 321(v), because it is not generally recognized among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. [read post]
11 Feb 2013, 2:57 pm
In any event, while some courts get caught up in this argument, others – like the court in Caplinger v. [read post]
15 Feb 2013, 11:29 am
Over at the Drug and Device Law Blog, there are several posts analyzing the meaning of the Second Circuit’s opinion in United States v. [read post]
5 Apr 2007, 5:39 am
Weiss v. [read post]
19 Dec 2013, 6:12 am
” Bailey v. [read post]
26 Aug 2024, 7:56 pm
Amarin Pharma Inc. v. [read post]
